ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Leucine and protein metabolism in obese Zucker rats.

肥満Zuckerラットにおけるロイシンとタンパク質代謝 (機械翻訳の邦題)

PloS one2013She P, Olson KC, Kadota Y, et al.
研究デザインその他の原著論文
対象動物

記録の確認項目

研究デザイン
その他の原著論文
対象
動物
出版年
2013
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

肥満における分岐鎖アミノ酸(BCAA)上昇の機序を解明するため、肥満Zuckerラットを用いて、メタボロミクスと[1-14C]ロイシン代謝、組織特異的タンパク質合成、分岐鎖ケト酸脱水素酵素複合体(BCKDC)活性を測定した。肥満ラットでは体重、肝臓重量、脂肪量が増加し、筋肉量は減少した。血漿BCAAとBCKAは上昇し、その要因として摂食量増加、ロイシン回転とタンパク質分解の亢進、組織あたりのBCKDC活性低下が示唆された。一方、全身および肝臓でのタンパク質合成は増加し、ロイシン酸化も亢進した。肝臓ではBCKDC活性の低下を肝重量増加が補い、基質効果により酸化亢進に寄与した可能性がある。血漿BCKAはBCAAより肥満の感受性マーカーであることが示唆された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Branched-chain amino acids (BCAAs) are circulating nutrient signals for protein accretion, however, they increase in obesity and elevations appear to be prognostic of diabetes. To understand the mechanisms whereby obesity affects BCAAs and protein metabolism, we employed metabolomics and measured rates of [1-(14)C]-leucine metabolism, tissue-specific protein synthesis and branched-chain keto-acid (BCKA) dehydrogenase complex (BCKDC) activities. Male obese Zucker rats (11-weeks old) had increased body weight (BW, 53%), liver (107%) and fat (∼300%), but lower plantaris and gastrocnemius masses (-21-24%). Plasma BCAAs and BCKAs were elevated 45-69% and ∼100%, respectively, in obese rats. Processes facilitating these rises appeared to include increased dietary intake (23%), leucine (Leu) turnover and proteolysis [35% per g fat free mass (FFM), urinary markers of proteolysis: 3-methylhistidine (183%) and 4-hydroxyproline (766%)] and decreased BCKDC per g kidney, heart, gastrocnemius and liver (-47-66%). A process disposing of circulating BCAAs, protein synthesis, was increased 23-29% by obesity in whole-body (FFM corrected), gastrocnemius and liver. Despite the observed decreases in BCKDC activities per gm tissue, rates of whole-body Leu oxidation in obese rats were 22% and 59% higher normalized to BW and FFM, respectively. Consistently, urinary concentrations of eight BCAA catabolism-derived acylcarnitines were also elevated. The unexpected increase in BCAA oxidation may be due to a substrate effect in liver. Supporting this idea, BCKAs were elevated more in liver (193-418%) than plasma or muscle, and per g losses of hepatic BCKDC activities were completely offset by increased liver mass, in contrast to other tissues. In summary, our results indicate that plasma BCKAs may represent a more sensitive metabolic signature for obesity than BCAAs. Processes supporting elevated BCAA]BCKAs in the obese Zucker rat include increased dietary intake, Leu and protein turnover along with impaired BCKDC activity. Elevated BCAAs/BCKAs may contribute to observed elevations in protein synthesis and BCAA oxidation.

MeSH

3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)Adipose TissueAmino Acids, Branched-ChainAnimalsBiomarkersBody WeightCarbon RadioisotopesCarnitineChromatography, LiquidCreatinineLeucineLiverMaleMetabolomicsMuscle, SkeletalObesityOrgan SizeProteinsRatsRats, ZuckerTandem Mass Spectrometry

DOI 10.1371/journal.pone.0059443

PMID 23527196

原文・出典を見る →